Streetbeat News

Stock Prices

MRK

SMMT

Merck & Co Inc (MRK) and Daiichi Sankyo's lung cancer drug, patritumab deruxtecan, met its primary endpoint in a phase 3 trial, showing significant improvement in progression-free survival for EGFR-mutated NSCLC patients. The safety profile was consistent with previous trials. Meanwhile, Summit Therapeutics' ivonescimab showed better results than Merck's Keytruda in a separate trial.

Portfolio Pulse from Vandana Singh

September 17, 2024 | 11:58 am

DRMA

Dermata Therapeutics shares fell following the announcement of a $3.5 million private placement involving 1,912,569 shares of common stock and short-term series B warrants priced at $1.83 per share.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:56 am

ABBV

BJ

SMH

TDG

On CNBC's 'Final Trades,' experts recommended TransDigm, BJ's Wholesale, VanEck Semiconductor ETF, and AbbVie. TransDigm and BJ's reported strong financial results, while AbbVie received Health Canada approval for a new treatment. VanEck Semiconductor ETF was suggested as a buy due to a recent sector decline.

Portfolio Pulse from Avi Kapoor

September 17, 2024 | 11:55 am

NCPL

Netcapital shares are experiencing a decline in trading following the release of their Q1 earnings report.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:54 am

BFI

BurgerFi's stock is rising following interim approval for $3.5 million in financing to aid its restructuring efforts across 144 locations.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:53 am

GS

Goldman Sachs maintains a bullish outlook on gold, expecting a price target of $2,700/oz by early 2025, driven by central bank demand and potential Fed rate cuts. Conversely, the bank has downgraded its iron ore forecast due to oversupply concerns, despite stabilizing demand from China.

Portfolio Pulse from Stjepan Kalinic

September 17, 2024 | 11:53 am

NUVL

Nuvalent's shares are trading lower following the announcement of a $500 million upsized public offering, pricing 5 million common shares at $100 each.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:52 am

IEP

Icahn Enterprises shares rose after a district court judge dismissed a class action lawsuit against the company, its directors, and officers without prejudice.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:51 am

HPE

Hewlett Packard Enterprise (HPE) shares rose following an upgrade by B of A Securities from Neutral to Buy, with a price target increase from $21 to $24.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:40 am

INTC

Intel shares rise following a strategic collaboration announcement with AWS to enhance US-based chip manufacturing.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:37 am